AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18557690
Drug: Present-centered group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Present-centered group therapy
Trial: 7729281
Drug: Mesalamine 4
RxNorm normalized name: mesalamine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine 4 g/day
Trial: 7729281
Drug: Mesalamine 1
RxNorm normalized name: mesalamine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine 1 g/day
Trial: 7729281
Drug: Mesalamine 2
RxNorm normalized name: mesalamine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine 2 g/day
Trial: 6452833
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DSCG and IPTB
Trial: 26627879
Drug: Enoxaparin/warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin/warfarin
Trial: 31415780
Drug: Nonsurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatment for stress urinary incontinence
Trial: 28262140
Drug: Medication only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication only condition (Control)
Trial: 26468123
Drug: Selenate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenate (400 μg/d)
Trial: 21877766
Drug: JP formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JP formulation of pitavastatin 2 mg
Trial: 21877766
Drug: EU formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EU formulation of pitavastatin 2 mg
Trial: 17479142
Drug: Treatment in
RxNorm normalized name: Other agents for local oral treatment in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment in stroke units
Trial: 17479142
Drug: Combined stroke
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined stroke units (offering both acute medical treatment and rehabilitation)
Trial: 9710685
Drug: pravastatin (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pravastatin (20-40 mg)
Trial: 7991936
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus glipizide (3 x 10 mg/day)
Trial: 8877026
Drug: Ketoconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200 mg)
Trial: 2499150
Drug: Terbinafine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (500 mg)
Trial: 25326831
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both supplements (PLX(®) and almond beverage)
Trial: 23281041
Drug: Add teriparatide
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Add teriparatide 20 µg/day
Trial: 23281041
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to teriparatide 20 µg/day
Trial: 18431541
Drug: Standard physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physical therapy (hot pack, ultrasound therapy, exercise program)
Trial: 18431541
Drug: Traction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traction therapy in addition to standard physical therapy
Trial: 16842389
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg rac-albuterol
Trial: 1666179
Drug: HOE 427
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 427 (ebiratide), administered intravenously in a pulsatile mode 4 times (120 micrograms each) at 2200, 2300, 2400 and 0100
Trial: 7066127
Drug: Buprenorphine 0.1
RxNorm normalized name: buprenorphine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.1 or 0.2 mg i.v. on patient demand using the 'Cardiff' palliator
Trial: 21078941
Drug: Quinine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine treatment
Trial: 17431728
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (n = 10) - 10-day course including thermal pool baths at 37 degrees C for 20 min two times daily
Trial: 23989945
Drug: Home treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home treatment
Trial: 22405255
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 μg vaginally, 2 tablets, 3 hours before abortion)
Trial: 19413507
Drug: Four‐Agents‐Decoction (Si
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four‐Agents‐Decoction (Si Wu Tang)
Trial: 15552635
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of 1000 mg extended-release divalproex sodium
Trial: 15552635
Drug: Evening dosing
RxNorm normalized name: Evening Dosing 24 HR Jornay 60 MG Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dosing of 1000 mg extended-release divalproex sodium
Trial: 11518478
Drug: Li 1370
RxNorm normalized name: LIS-1
DrugBank: LIS-1 (DB18388)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Li 1370 (240 mg)
Trial: 29366988
Drug: RG7652 (PCSK9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7652 (PCSK9 inhibiting antibody)
Trial: 24438596
Drug: Chlorhexidine gel
RxNorm normalized name: chlorhexidine Oral Gel
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gel (0.2%) application
Trial: 20490383
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (group 3)
Trial: 20490383
Drug: Declined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Declined treatment (group 2)
Trial: 14980948
Drug: 0.5% lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.5% lidocaine + 1 mL isotonic saline
Trial: 11601114
Drug: Bone grafting
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone grafting and substitutes (biologically inert, osteoconductive, or osteoinductive) and osteoinductive growth factors and hormones as supplements to treatment.
Trial: 9834259
Drug: Additional omeprazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional omeprazole, 20 mg at bedtime
Trial: 9834259
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg at bedtime
Trial: 9834259
Drug: Ranitidine, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 300 mg at bedtime
Trial: 7930273
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (1) streptokinase with intravenous heparin; (2) streptokinase with subcutaneous heparin; (3) accelerated-dose rt-PA with intravenous heparin; (4) combination of streptokinase and conventionally dosed rt-PA with intravenous heparin
Trial: 3207350
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice per day
Trial: 3207350
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg in a single dose at night
Trial: 28644348
Drug: 1-factor partial
RxNorm normalized name: ROSIN PARTIALLY DIMERIZED GLYCEROL ESTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-factor partial least squares model with L:M as dependent variable
Trial: 28644348
Drug: Adjusted models
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjusted models for L:M
Trial: 21442636
Drug: Pomalidomide therapy
RxNorm normalized name: Pomalidomide
DrugBank: Pomalidomide (DB08910)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Pomalidomide therapy
Trial: 19789514
Drug: Intravenous 0.5
RxNorm normalized name: immune globulin intravenous 0.5 g intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 0.5 mg/kg ketamine and peritonsillar 0.25% bupivacaine (3-5 ml per tonsil)
Trial: 19789514
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline and peritonsillar bupivacaine
Trial: 19789514
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and peritonsillar saline solution (placebo)
Trial: 16794136
Drug: IV bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV bolus injection of 2 mL/kg of nonionic iodine contrast material (300 mg I/mL) at 4 mL/s
Trial: 10678628
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy only (Group B)
Trial: 30636490
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of N-Acetylcysteine (IV: 25 mg/kg bolus and then 25 mg/kg/8 hours 3 times)
Trial: 30636490
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of N-Acetylcysteine (IV: 25 mg/kg bolus and then 75 mg/kg over 24 hours)
Trial: 15156070
Drug: Carbatrol (CBR)
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbatrol (CBR) at dosages of 800, 1200, 1600 mg/day
Trial: 3290356
Drug: Ketanserin treatment
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin treatment for 5 weeks
Trial: 17687099
Drug: Preventive treatment
RxNorm normalized name: STANNOUS FLUORIDE 0.004 g in 1 g DENTAL GEL [Enamelon Preventive Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive treatment strategies including mucolytic agents, physiotherapy, exercise, antibiotics, nutritional strategies, anti-inflammatory treatments, and vaccinations against common respiratory pathogens.
Trial: 2166699
Drug: Pork Insulin
RxNorm normalized name: Pork insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pork Insulin (PI)
Trial: 1643799
Drug: Human Insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human Insulin (HI)
Trial: 2166699
Drug: Pork Insulin
RxNorm normalized name: Pork insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pork Insulin (PI) after 20 min of hypoglycemia
Trial: 2166699
Drug: Human Insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human Insulin (HI) after 20 min of hypoglycemia
Trial: 31234651
Drug: Alternative medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative medicine strategies for diabetes control
Trial: 26505288
Drug: Pre-exposure to
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-exposure to tempting unhealthy food (e.g. candy)
Trial: 20709866
Drug: Acipimox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (250 mg, 4 times/day)
Trial: 17396059
Drug: Conventional Cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Cigarettes (CC)
Trial: 15878496
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate combination (SFC) product (50/250 microg bid via the Diskus inhaler)
Trial: 11888872
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (axillary RT and no axillary treatment)
Trial: 28594783
Drug: 17α‐hydroxyprogesterone caproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17α‐hydroxyprogesterone caproate (341 mg per week)
Trial: 28594783
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (200 mg per day)
Trial: 12765424
Drug: mepolizumab (SB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mepolizumab (SB 240563) anti‐IL‐5 antibody administered three times
Trial: 9752908
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection transthecal technique using 3 cc of lignocaine and bupivacaine mixture
Trial: 8210390
Drug: Long-term low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Long-term low-dose erythromycin therapy (200 mg three times daily)
Trial: 3333017
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg stanozolol daily for 12 weeks
Trial: 23666681
Drug: NT‐proBNP‐guided therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT‐proBNP‐guided therapy
Trial: 22282728
Drug: 6.3 mm-long
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.3 mm-long implants
Trial: 22282728
Drug: 9.3 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9.3 mm or longer implants
Trial: 1822264
Drug: Trandolapril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril (2 mg/day)
Trial: 18443191
Drug: Non-ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ACE inhibitor therapy
Trial: 17343258
Drug: Control period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control period (2 weeks without treatment)
Trial: 14665584
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate ingestion (1 litre of solution containing 0.5 g of sodium citrate/kg body mass two hours before the run)
Trial: 6202971
Drug: Atenolol (0.19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (0.19 mg/kg)
Trial: 7986160
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no beta-blocker)
Trial: 20031608
Drug: Atenolol treatment
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol treatment
Trial: 6202971
Drug: Practolol treatment
RxNorm normalized name: practolol
DrugBank: Practolol (DB01297)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol treatment
Trial: 29313286
Drug: Once-daily single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily single inhaler triple therapy (fluticasone furoate/umeclidinium/vilanterol) 100 µg/62.5 µg/25 µg
Trial: 29313286
Drug: Twice-daily inhaled
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily inhaled corticosteroid/long-acting β2-agonist therapy (budesonide/formoterol) 400 µg/12 µg
Trial: 23089047
Drug: Benzalkonium chloride
RxNorm normalized name: Benzalkonium Chloride
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzalkonium chloride (BZK) gel
Trial: 23089047
Drug: Nonoxynol-9 (N-9)
RxNorm normalized name: Nonoxynol 9
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoxynol-9 (N-9) gel
Trial: 18713505
Drug: End-of-treatment chest
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End-of-treatment chest radiograph (EOT CXR) showing persistent cavity
Trial: 18713505
Drug: End-of-treatment chest
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End-of-treatment chest radiograph (EOT CXR) showing resolved cavity
Trial: 9236420
Drug: Xemilofiban 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xemilofiban 35 mg orally before and 20 to 25 mg TID for 30 days after angioplasty
Trial: 12824459
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg per day)
Trial: 11584088
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation
Trial: 22888611
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplementation
Trial: 1905836
Drug: Immune serum
RxNorm normalized name: IMMUNE SERUMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune serum globulin (ISG) 2 ml i.m. at premedication and 2 ml i.m. on postoperative day 3
Trial: 1593145
Drug: Bupivacaine hydrochloride
RxNorm normalized name: Bupivacaine Hydrochloride
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupivacaine hydrochloride (one ml) and buprenorphine 300 micrograms in combination (Group B)
Trial: 20350428
Drug: Probiotics treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics treatment group (Clostridium butyricum powder, 250 mg, twice daily up to discharge)
Trial: 20350428
Drug: Probiotics treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics treatment group
Trial: 17604473
Drug: Clofibate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofibate (100 mg/kg single oral dose)
Trial: 10843152
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg
Trial: 12425125
Drug: Rocuronium, 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium, 0.03 mg/kg
Trial: 1736336
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole once daily for 2 weeks
Trial: 3512351
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole once daily for 4 weeks
Trial: 2011700
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ranitidine once daily for 4 weeks
Trial: 6399407
Drug: Tinidazole (2-gram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (2-gram single dose)
Trial: 23115322
Drug: Beta-blocker dose
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker dose
Trial: 26212489
Drug: EE/DRSP (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EE/DRSP (20 μg EE/3 mg DRSP)
Trial: 17645506
Drug: Epoetin 150
RxNorm normalized name: METHOXY PEG-EPOETIN 150MCG/0.3ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin 150 IU/kg three times weekly
Trial: 11310081
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy during the examination
Trial: 8707479
Drug: Placebo EMF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo EMF treatment
Trial: 22644797
Drug: 5-mg axitinib
RxNorm normalized name: axitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg axitinib Form XLI FCIR tablets with moderate-fat, standard-calorie meal
Trial: 22644797
Drug: 5-mg axitinib
RxNorm normalized name: axitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg axitinib Form XLI FCIR tablets
Trial: 20196093
Drug: Recruitment strategies
RxNorm normalized name: Humanized Bi-Specific Xmab(R) T Cell Recruiting Antibody Construct Directed Against Cd3 And Cd38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recruitment strategies including relationship-building, raffles, and screening survey administration
Trial: 11349741
Drug: Intravenous fludarabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fludarabine
Trial: 8548235
Drug: Preoperative total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative total parenteral nutrition (TPN)
Trial: 28924473
Drug: Chlorhexidine-alcohol combination
RxNorm normalized name: chlorhexidine / isopropyl alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine-alcohol combination (product B) applied for 180 s
Trial: 23483223
Drug: H-FABP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-FABP levels in SCI patients (paraplegia group: 18.5 ± 11.4 ng/ml; tetraplegia group: 16.3 ± 9.1 ng/ml)
Trial: 23483223
Drug: H-FABP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-FABP levels in complete SCI patients with lesions above T6 (24.21 ± 10.1 ng/ml)
Trial: 23483223
Drug: H-FABP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-FABP levels in SCI patients with metabolic syndrome (MetS) (25.8 ± 11.6 ng/ml)
Trial: 19451819
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progesterone replacement therapy
Trial: 8390232
Drug: Washout group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Washout group (post-treatment follow-up)
Trial: 25219563
Drug: ProQuad® (MMRV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ProQuad® (MMRV) first dose
Trial: 25219563
Drug: ProQuad® (MMRV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ProQuad® (MMRV) second dose
Trial: 9444543
Drug: Placebo (8-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (8-week treatment)
Trial: 11020749
Drug: Caudal S(+)-ketamine
RxNorm normalized name: (S)-(-)-ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal S(+)-ketamine 1 mg/kg
Trial: 11020749
Drug: Intramuscular S(+)-ketamine
RxNorm normalized name: (S)-(-)-ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular S(+)-ketamine 1 mg/kg